HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

HNAB: Hana Biosciences Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
HANA BIOSCIENCES INC (OTCBB)
HNAB 0.50 -0.05 (-9.09%) Vol.  25,630 14.00 CST

Nov 13, 2009 Hana Biosciences Announces Third Quarter 2009 Results
Nov 05, 2009 Delisting of Securities of Hana Biosciences, Inc. From The NASDAQ Stock Market
Oct 22, 2009 Hana Biosciences to Present at the 8th Annual BIO Investor Forum
Oct 13, 2009 Hana Biosciences Completes Private Placement
Oct 09, 2009 Stockguru.com: Hana Biosciences Inc. is in the StockGuru Spotlight for October 9, 2009
Oct 09, 2009 Pinnacle Digest: Opinions Requested on Completion of Private Placement: Review Initiated by Online Financial Magazine
Oct 08, 2009 Hana Biosciences Completes $12.4 Million Private Placement
Oct 08, 2009 Hana Biosciences Announces $12.4 Million Private Placement
Sep 30, 2009 HNAB: Clinical Trial Agreement w/National Cancer Institute for Marqibo(R)
Sep 30, 2009 Hana Biosciences Enters Into Clinical Trial Agreement With the National Cancer Institute for Development of Marqibo(R) in Pediatric Cancer
Sep 14, 2009 Hana Biosciences Gets Delisting Note From NASDAQ
Sep 11, 2009 Hana Biosciences Gets Delisting Note From NASDAQ
Sep 08, 2009 Hana Biosciences Receives NASDAQ Delisting Notification
Aug 14, 2009 Hana Biosciences Announces Second Quarter 2009 Results
Aug 13, 2009 Hana Biosciences Reaches Patient Target For Marqibo Trial
 
ZACKS COMMENTARY FOR HNAB

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research